<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/767C83D0-2A56-4E64-BF98-B8F6933A9AF8"><gtr:id>767C83D0-2A56-4E64-BF98-B8F6933A9AF8</gtr:id><gtr:name>Evotec</gtr:name><gtr:address><gtr:line1>114 Milton Park
Abingdon</gtr:line1><gtr:city>Oxford</gtr:city><gtr:postCode>OX14 4SA</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CF11C8EB-DE92-4FC8-8F5D-477390597C44"><gtr:id>CF11C8EB-DE92-4FC8-8F5D-477390597C44</gtr:id><gtr:name>McMaster University</gtr:name><gtr:address><gtr:line1>1280 Main Street West</gtr:line1><gtr:line4>Hamilton, Ontario</gtr:line4><gtr:line5>L8S 4L8</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/767C83D0-2A56-4E64-BF98-B8F6933A9AF8"><gtr:id>767C83D0-2A56-4E64-BF98-B8F6933A9AF8</gtr:id><gtr:name>Evotec</gtr:name><gtr:address><gtr:line1>114 Milton Park
Abingdon</gtr:line1><gtr:city>Oxford</gtr:city><gtr:postCode>OX14 4SA</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CF11C8EB-DE92-4FC8-8F5D-477390597C44"><gtr:id>CF11C8EB-DE92-4FC8-8F5D-477390597C44</gtr:id><gtr:name>McMaster University</gtr:name><gtr:address><gtr:line1>1280 Main Street West</gtr:line1><gtr:line4>Hamilton, Ontario</gtr:line4><gtr:line5>L8S 4L8</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6E3E3635-ED48-40A3-A8DA-3C19F94A1AB6"><gtr:id>6E3E3635-ED48-40A3-A8DA-3C19F94A1AB6</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Piddock</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1F334B11-EF39-43F6-B82D-C0E16381B4B6"><gtr:id>1F334B11-EF39-43F6-B82D-C0E16381B4B6</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Busby</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801977"><gtr:id>4F6C618E-18DA-4210-B6C8-33D9CEF0F7C4</gtr:id><gtr:title>Un-ravelling the network of regulation of multidrug resistance in Salmonella enterica</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801977</gtr:grantReference><gtr:abstractText>Every year people are exposed to non-typhoidal salmonella bacteria, typically from contaminated foodstuffs. Some people succumb to infection and get ill. This is particularly dangerous for the very old and young, and these people often need treatment with antibiotics. Unfortunately, antibiotic resistance in salmonella is not uncommon. In this project we will perform experiments that will allow us to understand how multiple antibiotic (drug) resistance (MDR) is caused. We will identify genes and/or the proteins that control the production of the AcrAB-TolC system, which exports antibiotics from the bacterial cell and so allows it to continue to grow and cause infection. If this system is inactivated the bacterium becomes very susceptible to antibiotics, finds it difficult to colonise the host (e.g. poultry) and antibiotic resistant salmonella are hard to select. We anticipate that we will find proteins that confer MDR and that can also be used as targets for drugs that will inhibit production of AcrAB-TolC. Such new drugs would make it difficult for the salmonella to cause infection and be antibiotic resistant.</gtr:abstractText><gtr:technicalSummary>The AcrAB-TolC efflux pump in Salmonella enterica serovar Typhimurium confers innate multiple drug resistance (MDR), and is important in colonisation and persistence in poultry ? the primary reservoir. In isolates from humans and animals it confers clinically relevant MDR. Genetic inactivation of AcrAB-TolC confers antibiotic hyper-susceptibility, attenuates the organism and makes it difficult to select antibiotic resistant bacteria. In salmonella RamA, a member of the AraC-XylS family of transcriptional activators, can regulate expression of acrAB and tolC. Over-production of RamA confers MDR whereas in Escherichia coli MarA plays this role. However, in salmonella there are data to indicate that expression of acrAB and tolC is regulated, and MDR also conferred, by other factors. The purpose of this project is to advance our understanding of the mechanisms by which MDR via over-production of AcrAB-TolC is conferred. Four hypotheses will be explored (1) in salmonella RamA and MarA have distinct, but over-lapping, regulons; (2) RamA is the primary regulator of expression of the AcrAB-TolC efflux pump in those Enterobacteriaeceae that possess this gene, and MarA only plays a role in those bacteria that do not possess ramA (e.g. E. coli and Shigella spp); (3) both ramA/RamA and marA/MarA are regulated by other factors, possibly another regulator, which when mutated confers MDR; (4) expression of acrAB and tolC is regulated by a factors and/or gene/s other than local repressors, ramA or marA. A systems biology approach will be taken using microbiology, molecular genetics, cell biology and in vivo models and include new and novel techniques including ChIP and DNA sampling. This research project will make new and important scientific advances in how efflux pumps are regulated and this information will be relevant to those serovars that cause enteric fever, Typhi and Paratyphi, plus other Enterobacteriaceae.</gtr:technicalSummary><gtr:fund><gtr:end>2014-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1367543</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Paul Williams</gtr:description><gtr:id>43ED0287-406A-41A0-8DDC-D307FC9120D4</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:partnerContribution>To develop the in vivo model of infection to measure efflux status, measurement of efflux inhibition in vivo</gtr:partnerContribution><gtr:piContribution>Construction of in-vivo reporter plasmids and reporter chromosomal mutants.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Microbiology and Infection</gtr:department><gtr:description>Vass Bavro</gtr:description><gtr:id>66BEA1C9-A51A-4035-9BF9-B3D92A9891C3</gtr:id><gtr:impact>None so far</gtr:impact><gtr:partnerContribution>Intellectual input and computer modelling</gtr:partnerContribution><gtr:piContribution>Experimental design, Intellectual input and experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Evotec</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Peter Warn (Evotec)</gtr:description><gtr:id>1D0C8613-078F-42EB-861C-FB0ABB6C5044</gtr:id><gtr:impact>NA</gtr:impact><gtr:partnerContribution>Industrial supervisor on an iCASE studentship (2016-2020). Will support student and provide experience in assays and diagnostic development .</gtr:partnerContribution><gtr:piContribution>Academic supervisor on iCASE studentship and provision of research facilities for iCASE student</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Simon Gibbons</gtr:description><gtr:id>D11A92EC-D27D-4BBE-BB1B-DE7DD320ABB2</gtr:id><gtr:impact>None so far</gtr:impact><gtr:partnerContribution>Experimental design, Intellectual input and experiments</gtr:partnerContribution><gtr:piContribution>Experimental design, Intellectual input and experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Basel (Universit?t Basel)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Biozentrum Basel</gtr:department><gtr:description>Dirk Bumann</gtr:description><gtr:id>AB54244F-AFC4-43C1-AF88-5FC04059ACEA</gtr:id><gtr:impact>We have exploited GFP reporter fusions to measure RamR-dependent regulation of the ramA promoter, which confirmed the identification of the DNA target for RamR. We also utilised the GFP reporter fusion to perform error prone PCR and create a mutant library in order to investigate which region(s) of the RamR protein interacts with the DNA target. A superrepressor mutant was identified. Published 2012, PMID:22948865
We have utilised a transcriptional GFP reporter system in order to identify compounds which increase the transcription of ramA. We found that in the the absence of a functional AcrAB-TolC efflux pump and with compounds that inhibit efflux ramA expression was induced. Published 2013, PMID:23493314</gtr:impact><gtr:partnerContribution>Provided us with promoterless GFP plasmid (pMW82)</gtr:partnerContribution><gtr:piContribution>Use of promoterless GFP plasmid to construct various GFP reporter fusions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McMaster University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Institute for Infectious Disease Research</gtr:department><gtr:description>Gerry Wright</gtr:description><gtr:id>C5A92AD4-2E90-4158-953D-74D72F8751DA</gtr:id><gtr:impact>None so far</gtr:impact><gtr:partnerContribution>Intellectual input, experimental design and experiments</gtr:partnerContribution><gtr:piContribution>Intellectual input, experimental design and experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Conference Talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2B6123DB-58EC-451D-8E19-CB16AF79042D</gtr:id><gtr:impact>08/09/16 Microbiology Society AGM Microbiology Society, London Prize winner lecture From outreach to basic research - addressing the crisis of AMR
28/09/16 Resistance and You! PHE, University of Manchester Speaker All about antibiotics - how they have changed our world
28/09/16 Resistance and You! PHE, University of Manchester Panel Chair Antibiotics and You!
07/11/16 Chevening leadership Foundation: R&amp;amp;D policy and strategies for innovation Chevening Foundation, London Speaker An overview of AMR, the scale of the problem and possible solutions
16/11/16 Plugging the Antibiotics Gap: A Medicinal Chemist's Perspective Royal Pharmaceutical Society, Alderley park, Cheshire Plenary speaker The global challenge of antibacterial drug resistance: what can be done?
13/01/17 Early Discovery of new antibiotics EU JPI AMR, Paris Panel Chair Analysis of the current European level portfolio: how to synergize the approaches, how to progress for new strategies / optimize funding around discovery
07/02/17 SHAMROCK annual lecture University of Sheffield Speaker Multi drug efflux systems: from basic research to discovering efflux inhibitors</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D40A8185-53C2-47F8-9491-C4194C87B40B</gtr:id><gtr:impact>460 students attended the lecture which sparked questions and discussions afterwards

-</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media actitivies</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6319FD5B-BC2F-4101-B387-C1717291384E</gtr:id><gtr:impact>Professor Laura Piddock gave interviews to local, national and international media (TV, Radio and print). In the last 12 months this has included: 
BBC Newsnight 
BBC Radio 4 
Live interview with Channel 4 
Sky News live interviews
Numerous Interviews about teixobactin including The Jeremy Vine Show, BBC Radio 2 (Jan 2015)
? Provided quote to The Independent (March 2015)
? Provided quotes to The Times, The Telegraph and The Independent on 'AncientBiotics' (March 2015).
? Letter to The Times,' Britain faces an 'antibiotic Armageddon' (April 2015)
? Filming for Panorama (April 2015)
? Interview with BBC Radio 4 'The Report' (April 2015)
BBC R4 Today x3

Various TV interviews syndicated worldwide including to CNN.
Global media coverage (quoted &amp;gt;200 times) following the WHO's report on 30 April 2014.
Federation of Infection Societies annual meeting: interview for short film: What is the cost of not developing another antibacterial drug
Numerous print and online media interviews including The Times, The Telegraph, The Daily Mail, The Daily Express, The Metro. Quotations have often been repeated in worldwide media including in USA print media.
BBC Horizon (broadcast 22 May 2014)
Swiss National Science Foundation (SNSF) National Research Programme (NRP) Steering Committee with the title &amp;quot;Antimicrobial Resistance: a one-health approach&amp;quot;
Plenary lecture at the 'Stimulating Antimicrobial Innovation' one day meeting at the NHLI, Imperial College London on October 22nd 2015. This is being organised by the Academy of Pharmaceutical Sciences GB, through the focus group on Microbiology and Anti-infectives. 
Board of Examiners in Biochemistry and Biotechnology at Imperial College London, I am writing to invite you to join us as an External Examiner for our BSc courses commencing with the 2015/16 academic year
Invitation to be a panellist at BioInfect 2015
Guest lecture on antibiotic resistance for a new course we are developing as part of the University of Glasgow online learning course.
Plenary Lecture Invitation: Research Day-St George's University of London 2 Dec talk on the subject of 'The challenges of AMR' at the launch of our new EPSRC funded AMR 'Bridging the Gaps' launch event University of Loughborough 7 Dec
Swedish Research Council review panel to evaluate applications for a Networking call to bring together researchers from Sweden and India on e-Science for Life Science and Antibiotic resistance in a 'One Health' perspective
Science Foundation Ireland review panel, Dublin SFI Investigators Programme 25th and 26th of February 2016.
European Science Foundation Invitation to join Review Panel on AXA postdoctoral fellowships 2016 meetings in Feb and May 2016
ZIBI Interdisciplinary Center for Infection Biology and Immunity
 Symposium Therapeutic Resistances in Infectious Disease - Status Quo and Future Challenges, Berlin (June 27/28, 2016
Science Representative of the Buckinghamshire Federation of Women's Institutes to warmly invite you to speak at our science Investigation and Discovery Day on 7 March, in Aylesbury
Invitation to Convene and speak in symposium: 2016 ASM Microbe plenary session
Plenary lecture on AMR at the IPS conference September 2016 
'Turn your nose up' campaign with the Farms not Factories organisation
 Took part in a written panel interview which will appear in Future Medicinal Chemistry's upcoming New Frontiers in Antimicrobial Drug Discovery special issue
? Interviewed by Bloomberg News, Australia
? Invited to interview with The Naked Scientist
Flix Interactive about a Wellcome Trust funded project on an antimicrobial resistance computer game
? Release of BSAC policies on antimicrobial use in animals and humans (May).
? Interviewed by The Atlantic on the O'Neill Report, LJVP, (May).
? Interviewed by BBC Radio 4 Today programme (1:22), LJVP (May).
? Interviewed by BBC2 Victoria Derbyshire programme (May).
? Interviewed by BBC Radio 4 Today programme (2:25) LJVP, (May).
? Interviewed by BBC World on superbugs, LJVP, (May). 
? Invited to interview by Good Morning Britain about the O'Neill Report, LJVP, (May)
? Interviewed by Kevin Fong, National Geographic, LJVP (May).
? Interviewed by Bang! Oxford University's Science Magazine, LJVP (May).
? Interviewed by a 7th grader for a project on antibiotic resistance, LJVP (May).
? Interviewed by the Daily Mail Good Health, LJVP (May).
? Provided comment to Science Media Centre on colistin-resistant bacteria in US woman, LJVP (May).
? Invited to attend the UK premier of the documentary &amp;quot;Clean Hands&amp;quot;, 28th June, London, LJVP (May).
? Invited to interview by The Los Angeles Times, LJVP (June).
? BBC Radio 4 'In our Time' programme, Penicillin, 9th June 2016, LJVP (June).
? Invited to interview by &amp;quot;Sputnik - Orbiting the World with George Galloway&amp;quot;, LJVP (June)
? Invited to write an article for The Conversation, LJVP (June).
? Reviewed and edited the script for a cartoon series generated by the Dundee Design School, LJVP (June).
? Invited to write an article for the Spanish newspaper 'El Pa&amp;iacute;s, LJVP (June).
? Provided a quote to the British Medical Journal for a feature on the impact of NICE sepsis guidance on antibiotic subscribing, LJVP (June).
? Provided NICHE with Antibiotic Action posters.
? Invited to join expert panel for Innovate UK and Department of Health Funding competition: antimicrobial resistance, 29th November (Oct)
? Invited by the Food Standards Agency and the Universities of Southampton and Newcastle, to participate in a joint antimicrobial resistance workshop. (Oct)
? Invited to give a plenary lecture on antimicrobial resistance at the St George's Annual Research Day. (Oct)
? Interviewed by the Sunday Express. (Oct)
? Interview with Strategy&amp;amp; for a 'State of the Nation report' into AMR research &amp;amp; development in the UK. (Oct)
? Invited to provide quotes to the Bureau of Investigative Journalism on the topic of antimicrobial resistance. (Oct)
? Attended the 75th anniversary of penicillin, 7 November, University of Oxford. (LJVP) 
? Invited to appear and provide expertise in a BBC4 documentary with Michael Moseley
? Supplement in the Guardian (Media Planet) under the One Health Agenda
? Twitter: True Stories on video joint release with PHE (stories embargoed by PHE plus BBC Radio 4 stories and Tony Maxwell videos
? Interview with Good Housekeeping magazine for WAAW
? Invited to provide a comment on 'everyday germs in the home, their effects and how you can reduce the risk of illness' for a campaign run by Domestic Innovations. (July)
? Working with BBC Five Live on concerns in relation to availability of antibiotics via online pharmacies. 
? Invited to provide comment for a story the Guardian are covering that looks at an antibiotic that kills Staphylococcus aureus. (July)
? Invited to interview with TIME magazine about the anthrax outbreak in Russia
? To provide expertise on a script for a feature film under development by Neon Films
? To provide a quote for the cover of a forthcoming science book by the Royal Society of Chemistry 'The Microbes Fight Back: Antibiotic Resistance' 
? Interviewed by James Gallagher, BBC Health website - UN Resolution. (Sept)
? Interview with BBC Radio 5 Live Drive - UN Resolution. (Sept)
? Interviewed with Deutsche Welle Television, Berlin - UN Resolution. (Sept)
? Interviewed by The Lancet Infectious Disease on UN Resolution to be published in November. (Sept)
? Interview with BBC World Service - The Inquiry to discuss the antibiotics crisis, following the recent UN meeting.
? Interview with BBC News - UN Resolution. (Sept


Promotion of Antibiotic Action (AA) being led by Prof. Laura Piddock. Antibiotic Action is a global initiative by the British Society for Antimicrobial Chemotherapy (BSAC) to highlight the threat to world health from multi-drug resistant bacteria and lobby for urgent action to develop new antimicrobial treatments</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>96000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE</gtr:description><gtr:end>2020-10-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>E1102B82-C204-49B1-9698-C0909F0D3A4F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>460000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Roche</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Roche</gtr:fundingOrg><gtr:id>E28BEF29-4023-4BF5-AE51-6B1DC09B56E6</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>163253</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Innovate Theme 2</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>8ADD0106-5CBA-476D-858B-2B62143AFB6B</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Longitude Prize Expert Advisory Panel</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B171464A-386C-4706-9A8C-80A218EF1277</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Antibiotic Strategy, Department of Health</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>83E7FE34-928F-4AC4-84BC-558B29D52979</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>O'Neil AMR Review</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9711A846-859B-4C29-A9DE-0C1429C3BFCC</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Medical Research Council Cross Funder AMR committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3938A02C-A403-455A-A11E-5DFBF2799777</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Antibiotic Action</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>457870A0-44D0-4C10-AEDB-50FB44BBE875</gtr:id><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BSAC, The Urgent Need for New Antibiotics</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D9123BD7-3A38-4AEB-92C7-D47F979F2761</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EU Joint Programming Initiative on AMR Scientific Advisory Board</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4EE8BE1E-FDA1-400F-8ED1-46A16464B40F</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisor to CMO on antibiotics</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9D8DF9E2-DFD8-4C84-BBBF-40A964D5F6B5</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Secreteriat APPG on Antibiotics</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0202BCE2-9499-4E3C-AE7D-614B2974F3E5</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A GFP reporter is used to screen a compound library using the Birmingham Drug Discovery Facility, which contains a whole cell high throughput screening (HTS) platform.</gtr:description><gtr:id>D2B3B6B5-E534-4181-9F37-A243EB4C9FA7</gtr:id><gtr:impact>Following a preliminary study the data was used as the basis of a successful research grant application with Roche.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>High throughput screening of compound libraries</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Promoters of interest were fused to GFP on a plasmid, these constructs were transformed into various backgrounds and induction of GFP was performed with a variety of compounds. High throughput was attained by using a 96 well format and utilising a FluoSTAR OPTIMA to measure fluoresence.</gtr:description><gtr:id>F7B271CB-FE57-460C-A81A-94C9E2C1B4A2</gtr:id><gtr:impact>We have been able to evaluate numerous compounds on their ability to induce our genes of interest. This tool gives the ability to screen for inhibitors of efflux in bacteria.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>High througput GFP induction assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A transposon library containing a GFP reporter gene is screened using flow cytometry. Populations with increased fluorescence are sorted and then whole genomes of the sorted population are sequenced to identify the gene/s conferring altered production of ramA or acrB.</gtr:description><gtr:id>6BA63979-302B-4EF8-8F72-142E1D9D6422</gtr:id><gtr:impact>Proof of principle of success with this novel approach has been provided by recent experiments using a ramA reporter plasmid in a TraDIS library of S. Typhimurium (SL1344). DNA sequencing with transposon specific primers revealed five potential genes, the products of which have not been previously implicated as influencing expression of ramA.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>FACS selection of mutants with altered ramA or acrB expression</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1346A456-3C79-4526-B295-C0AEDA7BC89F"><gtr:id>1346A456-3C79-4526-B295-C0AEDA7BC89F</gtr:id><gtr:title>Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/63dd6bbb5971117dc0b87c2772e59f2a"><gtr:id>63dd6bbb5971117dc0b87c2772e59f2a</gtr:id><gtr:otherNames>Webber MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA33C26A-8404-4917-8475-CA0FF5ACF253"><gtr:id>BA33C26A-8404-4917-8475-CA0FF5ACF253</gtr:id><gtr:title>The TCA cycle is not required for selection or survival of multidrug-resistant Salmonella.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbc6abb924dee6661a8b8ebc5febb488"><gtr:id>fbc6abb924dee6661a8b8ebc5febb488</gtr:id><gtr:otherNames>Ricci V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3DC6A8E-BB6A-445E-800C-2119AB1C354F"><gtr:id>C3DC6A8E-BB6A-445E-800C-2119AB1C354F</gtr:id><gtr:title>RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbc6abb924dee6661a8b8ebc5febb488"><gtr:id>fbc6abb924dee6661a8b8ebc5febb488</gtr:id><gtr:otherNames>Ricci V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6819E1C-29BA-4D71-9219-C82F50BF1943"><gtr:id>E6819E1C-29BA-4D71-9219-C82F50BF1943</gtr:id><gtr:title>Molecular mechanisms of antibiotic resistance.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/19aeca31db2156b30e754efe006dd3a2"><gtr:id>19aeca31db2156b30e754efe006dd3a2</gtr:id><gtr:otherNames>Blair JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/614B73B2-1320-4F78-884B-1AFC1F3DC41E"><gtr:id>614B73B2-1320-4F78-884B-1AFC1F3DC41E</gtr:id><gtr:title>Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.</gtr:title><gtr:parentPublicationTitle>Future microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/19aeca31db2156b30e754efe006dd3a2"><gtr:id>19aeca31db2156b30e754efe006dd3a2</gtr:id><gtr:otherNames>Blair JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1746-0913</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16248FAE-0DC8-4C15-9019-1763C3A496F5"><gtr:id>16248FAE-0DC8-4C15-9019-1763C3A496F5</gtr:id><gtr:title>Regulation of RamA by RamR in Salmonella enterica serovar Typhimurium: isolation of a RamR superrepressor.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbc6abb924dee6661a8b8ebc5febb488"><gtr:id>fbc6abb924dee6661a8b8ebc5febb488</gtr:id><gtr:otherNames>Ricci V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AFE0E869-600D-4282-BAE9-982610B94D6E"><gtr:id>AFE0E869-600D-4282-BAE9-982610B94D6E</gtr:id><gtr:title>Genetic inactivation of acrAB or inhibition of efflux induces expression of ramA.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91579e4df762a86510732d3d153f44c7"><gtr:id>91579e4df762a86510732d3d153f44c7</gtr:id><gtr:otherNames>Lawler AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801977</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>